Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuhiro Nakamura

Showing results (391-400 of 475) with videos related to

Pageof 48
Sort By:
Plos One|July 22, 2017
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report databaseShiori Hasegawa, Toshinobu Matsui, Yuuki Hane, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2019
Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databasesKazuyo Shimada, Shiori Hasegawa, Satoshi Nakao, et al.
SAGE Open Medicine|May 18, 2018
Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report databaseMisa Naganuma, Yumi Motooka, Sayaka Sasaoka, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 10, 2018
[Adverse Event Trends Associated with Over-the-counter Combination Cold Remedy: Data Mining of the Japanese Adverse Drug Event Report Database]Sayaka Sasaoka, Haruna Hatahira, Shiori Hasegawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 2, 2018
[Survey of Description on Package Inserts of OTC Drugs]Akari Shimauchi, Misa Naganuma, Sayaka Sasaoka, et al.
International Cancer Conference Journal|October 3, 2022
A case of a pregnant woman with locally advanced cervical esophageal cancer treated with definitive chemoradiotherapyYudai Tateishi, Katsuyuki Sakanaka, Hideaki Hirashima, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 3, 2019
Liver phantom design and dosimetric verification in participating institutions for a proton beam therapy in patients with resectable hepatocellular carcinoma: Japan Clinical Oncology Group trial (JCOG1315C)Teiji Nishio, Hidenobu Tachibana, Yuki Kase, et al.
Drugs - Real World Outcomes|August 6, 2022
Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) DatabaseShiori Hasegawa, Hiroaki Ikesue, Riko Satake, et al.
Cell Communication and Signaling : CCS|December 19, 2025
Galectin-3 in endometrial small extracellular vesicles promotes cytotrophoblast cell fusion during the implantation phaseTsutomu Ohara, Akihito Horie, Mitsuhiro Nakamura, et al.
Cureus|November 18, 2024
Comparison of Adverse Event Profiles of Amphotericin B Formulations Using Real-World DataYuka Nokura, Mika Maezawa, Koumi Miyasaka, et al.
Pageof 48

Showing results (391-400 of 475) with videos related to

Sort By:
Pageof 48
Plos One|July 22, 2017
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report databaseShiori Hasegawa, Toshinobu Matsui, Yuuki Hane, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2019
Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databasesKazuyo Shimada, Shiori Hasegawa, Satoshi Nakao, et al.
SAGE Open Medicine|May 18, 2018
Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report databaseMisa Naganuma, Yumi Motooka, Sayaka Sasaoka, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 10, 2018
[Adverse Event Trends Associated with Over-the-counter Combination Cold Remedy: Data Mining of the Japanese Adverse Drug Event Report Database]Sayaka Sasaoka, Haruna Hatahira, Shiori Hasegawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 2, 2018
[Survey of Description on Package Inserts of OTC Drugs]Akari Shimauchi, Misa Naganuma, Sayaka Sasaoka, et al.
International Cancer Conference Journal|October 3, 2022
A case of a pregnant woman with locally advanced cervical esophageal cancer treated with definitive chemoradiotherapyYudai Tateishi, Katsuyuki Sakanaka, Hideaki Hirashima, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 3, 2019
Liver phantom design and dosimetric verification in participating institutions for a proton beam therapy in patients with resectable hepatocellular carcinoma: Japan Clinical Oncology Group trial (JCOG1315C)Teiji Nishio, Hidenobu Tachibana, Yuki Kase, et al.
Drugs - Real World Outcomes|August 6, 2022
Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) DatabaseShiori Hasegawa, Hiroaki Ikesue, Riko Satake, et al.
Cell Communication and Signaling : CCS|December 19, 2025
Galectin-3 in endometrial small extracellular vesicles promotes cytotrophoblast cell fusion during the implantation phaseTsutomu Ohara, Akihito Horie, Mitsuhiro Nakamura, et al.
Cureus|November 18, 2024
Comparison of Adverse Event Profiles of Amphotericin B Formulations Using Real-World DataYuka Nokura, Mika Maezawa, Koumi Miyasaka, et al.
Pageof 48